HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yinying Lu Selected Research
Yinying Lu Research Topics
Disease
23
Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2009
19
Neoplasms (Cancer)
01/2022 - 01/2009
8
Neoplasm Metastasis (Metastasis)
01/2022 - 01/2009
5
Fibrosis (Cirrhosis)
01/2021 - 11/2014
3
Carcinogenesis
07/2021 - 05/2002
3
Disease Progression
01/2021 - 01/2021
2
COVID-19
07/2022 - 01/2022
2
Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 12/2020
2
Severe Fever with Thrombocytopenia Syndrome
05/2021 - 01/2020
2
Liver Neoplasms (Liver Cancer)
01/2021 - 08/2012
2
Hepatitis B
01/2021 - 01/2009
2
Hypertension (High Blood Pressure)
01/2021 - 01/2021
2
Cholangiocarcinoma
01/2020 - 11/2018
2
Carcinoma (Carcinomatosis)
07/2014 - 02/2013
1
Pathologic Processes
01/2022
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1
Hand-Foot Syndrome
01/2021
1
Hyperkalemia
01/2021
1
Intestinal Volvulus (Volvulus)
01/2021
1
Liver Failure
01/2021
1
Systemic Scleroderma (Systemic Sclerosis)
12/2020
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2020
1
Fever (Fevers)
01/2020
1
Infections
10/2019
Drug/Important Bio-Agent (IBA)
8
Proteins (Proteins, Gene)
FDA Link
07/2022 - 05/2002
8
Sorafenib (BAY 43-9006)
FDA Link
01/2021 - 02/2012
4
Biomarkers (Surrogate Marker)
IBA
01/2022 - 05/2015
3
MicroRNAs (MicroRNA)
IBA
01/2021 - 01/2017
2
Cell-Free Nucleic Acids
IBA
01/2022 - 01/2021
2
Enzymes
IBA
01/2022 - 07/2021
2
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2021
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 01/2009
2
Long Noncoding RNA
IBA
01/2021 - 12/2019
2
Cytokines
IBA
01/2021 - 01/2020
2
Messenger RNA (mRNA)
IBA
01/2021 - 11/2018
2
Pharmaceutical Preparations
IBA
12/2020 - 07/2014
2
Antineoplastic Agents (Antineoplastics)
IBA
10/2019 - 01/2018
2
Helium
IBA
11/2012 - 01/2009
2
Argon
IBA
11/2012 - 01/2009
1
Neutralizing Antibodies
IBA
07/2022
1
Immunoglobulin G (IgG)
IBA
07/2022
1
Peptides (Polypeptides)
IBA
07/2022
1
COVID-19 Vaccines
IBA
07/2022
1
Antibodies
IBA
07/2022
1
B-Lymphocyte Epitopes (B-Cell Epitope)
IBA
07/2022
1
Actin Depolymerizing Factors (Cofilins)
IBA
01/2022
1
Sirtuin 2
IBA
01/2022
1
Filamins
IBA
01/2022
1
Lysine (L-Lysine)
FDA Link
01/2022
1
protein K
IBA
01/2022
1
Carnitine (L-Carnitine)
FDA Link
Generic
01/2022
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2022
1
Citric Acid (Citrate)
FDA Link
Generic
01/2022
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
Ribosomal DNA (rDNA)
IBA
01/2022
1
Proteome
IBA
01/2022
1
Acetylcarnitine (Alcar)
IBA
01/2022
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2022
1
sodium-bile acid cotransporter
IBA
01/2022
1
Phenylalanine (L-Phenylalanine)
FDA Link
01/2022
1
3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanol
IBA
06/2021
1
Cilengitide
IBA
06/2021
1
RNA Helicases (RNA Helicase)
IBA
03/2021
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
03/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
apatinib
IBA
01/2021
1
Bevacizumab (Avastin)
FDA Link
01/2021
1
sintilimab
IBA
01/2021
1
Circular RNA
IBA
01/2021
1
Biosimilar Pharmaceuticals
IBA
01/2021
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2021
1
donafenib
IBA
01/2021
1
Antigens
IBA
01/2021
1
Fetal Proteins (Fetoprotein)
IBA
01/2021
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2021
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2021
1
saracatinib
IBA
12/2020
1
Small Interfering RNA (siRNA)
IBA
12/2020
1
src-Family Kinases
IBA
12/2020
1
Catenins
IBA
10/2020
1
Kinesins
IBA
10/2020
1
Bile Acids and Salts (Bile Acids)
IBA
01/2020
1
Endonucleases
IBA
01/2020
1
Blood Proteins (Serum Proteins)
IBA
01/2020
1
RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)
IBA
01/2020
1
ursodoxicoltaurine
IBA
01/2020
1
Immunologic Factors (Immunomodulators)
IBA
10/2019
1
ADAM17 Protein
IBA
10/2019
1
Chemokines
IBA
04/2019
1
Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)
IBA
04/2019
1
Actins (F Actin)
IBA
04/2019
1
Annexin A2 (Annexin II)
IBA
04/2019
Therapy/Procedure
10
Therapeutics
01/2022 - 06/2012
6
Cryosurgery
05/2015 - 01/2009
4
Cryotherapy (Therapy, Cold)
03/2015 - 02/2012
2
Immunotherapy
01/2021 - 10/2019
1
Molecular Targeted Therapy
01/2022
1
Drug Therapy (Chemotherapy)
01/2021
1
Oncolytic Virotherapy
10/2019
1
Lasers (Laser)
10/2019